No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples

Genetic Epidemiology

Volumn 14, Issue 3, 1997, Pages 299-305

  Fallin, Danielle ^a   Gauntlett, Ann C ^a   Scibelli, Paul ^a   Cai, Xingang ^a   Duara, Ranjan ^b   Gold, Michael ^a   Crawford, Fiona ^a   Mullan, Michael ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease risk; Genetic interaction; Very low density lipoprotein receptor gene

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION RESEARCH; RECEPTOR GENE;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, LDL; RISK FACTORS;

EID: 0030976712     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1997)14:3<299::AID-GEPI7>3.0.CO;2-0     Document Type: Article

References (13)

1. Bennett C, Crawford F, Osborne A, Diaz P, Hoyne J, Lopez R, Roques P, Duara R, Rossor M, Mullan M (1995): Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's disease but is not causative. Am J Med Genet Neuropsychiatr Genet 60:1-6.
2. Chung H, Roberts C, Greenberg S, Rebeck W, Christie R, Wallace R, Jacob H, Hyman B (1996): Lack of association of trinucleotide repeat polymorphisms in the very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann Neurol 6:800-803.
3. Jarvik GP, Larson EB, Goddard K, et al. (1996): Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 58:191-200.
4. Jokinen E, Sakai J, Yamamoto T, Hobbs H (1994): CGG triple repeat polymorphism in VLDL receptor (VLDL-R) gene. Hum Mol Genet 3:521.
5. Mullan M, Scibelli P, Duara R, Fallin D, Gold M, Schinka J, Hoyne J, Osborne A, Sevush S, Crawford F (1996): Familial and population based studies of APOE and AD. Ann NY Acad Sci 802:16-26.
6. Okuizumi K, Onedera O, Namba Y, Ikeda K, Yamamoto T, Seki K, Ueki A, Nanko S, Tanaka H, Takahashi H, Oyanagi K, Mizusawa H, Kanazawa I, Tsuji S (1995): Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet 11:207-209.
7. Okuizumi K, Onedera O, Seki K, Tanaka H, Namba Y, Ikeda K, Saunders A, Pericak-Vance M, Roses A, Tsuji S (1996): Lack of association of very low density lipoprotein receptor gene polymorphism in Caucasian Alzheimer's disease. Ann Neurol 40:251-254.
8. National Institute on Aging/Alzheimer's Association (NIA/AA) Working Group (1996): Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347:1091-1095.
9. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993): Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699.
10. Pritchard ML, Saunders PC, Gaskell GW, Small GW, Conneally PM, Rosi B, Yamaoka LH, Rose AD, Haines JL, Pericak-Vance MA (1996): No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci Lett 209:105-108.
11. Roses AD, Devlin B, Conneally PM, Small GW, Saunders AM, Pritchard M, Locke PA, Haines JL, Pericak-Vance MA, Risch N (1995): Measuring the genetic contribution of APOE in late-onset Alzheimer disease (AD). Am J Hum Genet 57(S):A202.
12. Strittmatter D, Saunders A, Schmechel D, Pericak-Vance M, Enghild I, et al. (1993): Apolipoprotein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset Alzheimer's disease. Proc Natl Acad Sci 90:1977-1981.
13. Wenham PR, Price WH, Blundell G (1991): Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158-1159.